(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.17%202.97B | 3.04%135.62B | 6.01%68.98B | 7.34%261.42B | 7.50%198.66B | 8.21%131.62B | 8.02%65.07B | 7.25%243.55B | 8.95%184.81B | 8.87%121.63B |
Operating income | 2.17%202.97B | 3.04%135.62B | 6.01%68.98B | 7.34%261.42B | 7.50%198.66B | 8.21%131.62B | 8.02%65.07B | 7.25%243.55B | 8.95%184.81B | 8.87%121.63B |
Cost of sales | ---- | -2.64%-94.84B | ---- | -6.96%-180.72B | ---- | -8.20%-92.4B | ---- | -7.26%-168.96B | ---- | -8.43%-85.4B |
Operating expenses | -1.97%-140.36B | -2.64%-94.84B | -5.63%-49.01B | -6.96%-180.72B | -7.15%-137.65B | -8.20%-92.4B | -7.95%-46.39B | -7.26%-168.96B | -8.65%-128.46B | -8.43%-85.4B |
Gross profit | 2.61%62.61B | 4.00%40.78B | 6.95%19.97B | 8.20%80.7B | 8.29%61.01B | 8.25%39.22B | 8.20%18.67B | 7.24%74.59B | 9.63%56.34B | 9.92%36.23B |
Selling expenses | 1.28%-28.79B | 0.43%-18.69B | -2.17%-9.03B | -6.16%-40.98B | -6.06%-29.16B | -6.60%-18.77B | -4.74%-8.84B | -5.51%-38.6B | -5.33%-27.5B | -5.24%-17.61B |
Administrative expenses | 4.52%-7.8B | 1.89%-11.01B | 4.08%-2.22B | -6.71%-23.15B | -5.64%-8.17B | -6.15%-11.22B | -5.66%-2.32B | -7.06%-21.7B | -2.05%-7.74B | -13.29%-10.57B |
Research and development expenses | -1.06%-8.13B | ---- | -7.42%-2.94B | ---- | -7.88%-8.05B | ---- | -10.26%-2.74B | ---- | -20.20%-7.46B | ---- |
Profit from asset sales | 80.79%-4.6M | ---- | 2,522.99%16.72M | ---- | -165.42%-23.92M | ---- | -157.47%-690.23K | ---- | -82.39%36.56M | ---- |
Revaluation surplus | -95.11%2.16M | ---- | -24.19%29.43M | ---- | 116.19%44.13M | ---- | 427.87%38.83M | ---- | -785.48%-272.6M | ---- |
-Changes in the fair value of other assets | -95.11%2.16M | ---- | -24.19%29.43M | ---- | 116.19%44.13M | ---- | 427.87%38.83M | ---- | -785.48%-272.6M | ---- |
Impairment and provision | 16.95%-1.02B | ---- | 38.19%-248.04M | ---- | 1.38%-1.23B | ---- | -15.02%-401.29M | ---- | -43.07%-1.24B | ---- |
-Other impairment is provision | 16.95%-1.02B | ---- | 38.19%-248.04M | ---- | 1.38%-1.23B | ---- | -15.02%-401.29M | ---- | -43.07%-1.24B | ---- |
Operating interest expense | ---- | -37.67%-1.22B | ---- | ---- | ---- | -149.01%-884M | ---- | ---- | ---- | 1.93%-355M |
Special items of operating profit | -0.16%2.46B | 9.11%1.84B | -19.70%697.18M | 18.88%3.46B | 7.99%2.47B | 23.00%1.69B | 10.13%868.24M | 41.48%2.91B | -0.68%2.28B | 38.51%1.37B |
Operating profit | 15.05%18.52B | 16.76%11.72B | 18.97%5.99B | 16.45%20.04B | 16.08%16.1B | 10.62%10.04B | 13.14%5.04B | 22.47%17.21B | 9.95%13.87B | 20.49%9.07B |
Financing cost | -205.18%-112.47M | ---- | -0.91%-207.19M | -111.74%-2.11B | -82.88%106.93M | ---- | -49.46%-205.33M | ---997M | 310.41%624.76M | ---- |
Share of profits of associates | ---- | -5.28%1.02B | ---- | 12.96%1.79B | ---- | 15.15%1.08B | ---- | -16.21%1.58B | ---- | -0.64%937M |
Special items of earning before tax | -42.99%13.89M | ---- | -376.46%-33.5M | ---- | 230.77%24.37M | ---- | -27.73%12.12M | ---- | -82.95%7.37M | ---- |
Earning before tax | 13.51%18.43B | 14.62%12.74B | 18.74%5.75B | 10.80%19.71B | 11.93%16.23B | 11.04%11.11B | 11.83%4.84B | 11.63%17.79B | 17.32%14.5B | 18.14%10.01B |
Tax | -0.65%-2.99B | -3.00%-2.13B | -10.23%-897.9M | 2.55%-2.98B | -6.50%-2.97B | -3.50%-2.07B | -8.07%-814.54M | -13.05%-3.06B | -22.22%-2.79B | -31.06%-2B |
After-tax profit from continuing operations | 16.39%15.44B | 17.28%10.61B | 20.46%4.85B | 13.57%16.73B | 13.22%13.26B | 12.92%9.04B | 12.63%4.03B | 11.34%14.73B | 16.21%11.71B | 15.30%8.01B |
Earning after tax | 16.39%15.44B | 17.28%10.61B | 20.46%4.85B | 13.57%16.73B | 13.22%13.26B | 12.92%9.04B | 12.63%4.03B | 11.34%14.73B | 16.21%11.71B | 15.30%8.01B |
Minority profit | 143.88%281.87M | 130.86%187M | 41.17%81.23M | 542.86%135M | 140.99%115.57M | 65.31%81M | 12.77%57.54M | -86.27%21M | -63.54%47.96M | -43.68%49M |
Profit attributable to shareholders | 15.27%15.15B | 16.26%10.42B | 20.16%4.77B | 12.81%16.6B | 12.69%13.15B | 12.60%8.96B | 12.62%3.97B | 12.49%14.71B | 17.26%11.67B | 16.05%7.96B |
Basic earnings per share | 16.31%1.64 | 17.71%1.13 | 20.93%0.52 | 13.29%1.79 | 12.80%1.41 | 12.94%0.96 | 13.16%0.43 | 12.06%1.58 | 16.82%1.25 | 14.86%0.85 |
Diluted earnings per share | 15.60%1.63 | 16.67%1.12 | 21.43%0.51 | 13.38%1.78 | 13.71%1.41 | 12.94%0.96 | 10.53%0.42 | 12.14%1.57 | 16.98%1.24 | 16.44%0.85 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Hexin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data